Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Helens HK$2.51 billion IPO
We advised the underwriter on the IPO and HKEX listing
PerkinElmer $2.3 billion senior notes offering
We advised the underwriters on the investment-grade debt offering
Toronto-Dominion Bank $4.5 billion notes offering
The investment-grade offering included multiple tranches of notes
Under Armour $169 million convertible notes exchanges
We advised the financial advisers to Under Armour on the exchange of convertible notes
Highland Transcend Partners I merger with Pharmapacks
We are advising Highland Transcend Partners I, a SPAC, on the transaction
Lionbridge Capital $150 million high-yield bonds offering
We advised the issuer and the guarantor on the offering
PGT Innovations $126 million acquisition of Anlin Windows & Doors
We are advising PGT on the acquisition and related financing arrangements
Pilgrim’s Pride $900 million senior notes offering
The high-yield offering involved 3.5% notes due 2032
Black Hills $600 million senior notes offering
We advised the joint book-running managers on the investment-grade debt offering
MultiPlan $1.05 billion notes offering and $1.775 billion credit facility
We advised the initial purchasers on the secured high-yield debt offering and the lead arrangers on the new credit agreement